About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials | 4,272 Studies Recruiting

Clinical TrialsSchizophrenia

Schizophrenia Clinical Trials

Browse 4,272 clinical trials for schizophrenia. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1461-1480 of 4,272 trials

TerminatedTranscranial Direct Current Stimulation Influences on Cognitive Inhibition in SchizophreniaA deficit in cognitive suppression is a trait of patients with schizophrenia.NCT01971073·Ramat Gan TerminatedEarly and Short Psycho-educational Lifestyle InterventionPeople with severe mental illness have an increased risk of somatic comorbidities such as metabolic syndrome, obesity, hypertension, dyslipidemia and diabetes mellitus, which…NCT02657941·Bron CompletedRemediation of Working Memory in SchizophreniaThe primary aim of the study is to test the efficacy of a novel cognitive remediation intervention that targets working memory-related functions.NCT00995553·Minneapolis, Minnesota

Related Searches

Data from ClinicalTrials.govTerms

CompletedFamily-Directed Cognitive Adaptation Program for Individuals With SchizophreniaThis is a pilot study evaluating the feasibility of a new family-based intervention for schizophrenia.NCT00434980·Boston, Massachusetts and 1 other

CompletedPsychosis and Affective Research Domains and Intermediate PhenotypesThe objective of this multi-site research collaboration is to test the manifestation and distribution of biological markers for psychosis and affect dimensions across the…NCT02218853·Dallas, Texas

CompletedGroup Training for Social Skills in PsychosisThe purpose of this study is to assess the feasibility of a social skills training group for people with psychosis.NCT02181777·London

Not yet recruitingEfficacy and Safety of Individualized Sequential Accelerated Theta Burst Stimulation in Improving Cognitive Function in SchizophreniaThe goal of this clinical trial is to learn if sequential dual-site accelerated theta burst stimulation (SD-aTBS) targeting the frontoparietal network and default mode network…NCT07806877

CompletedA Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I DisorderThe purpose of this study is to determine the safety and efficacy of topiramate in adolescents with manic or mixed episodes of Bipolar I Disorder.NCT00035802

CompletedEfficacy Study of a New Individualized Rehabilitation Programme for Social Cognition in Patients With SchizophreniaPatients affected by schizophrenia often present significant deficits in various aspects of social cognition, such as social perception, recognition of one's own and other…NCT05130853·Naples

CompletedA Study of Paliperidone Blood Concentrations in Patients With Schizophrenia After Administration of Paliperidone PalmitateThe purpose of this study is to evaluate the concentration of paliperidone in the blood after intramuscular injection in upper arm (deltoid muscle) or in the buttock (gluteal…NCT01110317

CompletedAn Open Label Study of Aripiprazole Intramuscular Injection in Subjects With SchizophreniaThe purpose of this study is to determine whether aripiprazole injection into the shoulder or the buttocks produces similar effects in the bodyNCT01646827·Cerritos, California and 5 others

UnknownEnhancing Social Interaction With an AlterEgo Artificial AgentThe objective of AlterEgo is the creation of an interactive cognitive architecture, implementable in various artificial agents, allowing a continuous interaction with patients…NCT02879591·Montpellier, Montpellier

CompletedA Study Of Adjunctive Treatment Of Cognitive Deficits In SchizophreniaThe objective of this study is to evaluate the safety, tolerability, and efficacy of two dose regimens of PF-3463275 compared with placebo added to ongoing atypical antipsychotic…NCT00567203·Glendale, California and 1 other

CompletedEMR Data to Assess Monitoring of Patients Treated With QuetiapineA study to evaluate the effectiveness of an update of educational materials with respect to evaluation of monitoring of metabolic parametersNCT01793324

CompletedEffect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in SchizophreniaThe purpose of study is to determine whether dietary supplement sarcosine is effective in treatment of schizophrenia.NCT01503359·Lodz, Czechosłowacka 8/10

CompletedSchizophrenia Study In AdultsA Placebo Controlled Study For Patients With SchizophreniaNCT00049946·Scottsdale, Arizona and 30 others

CompletedOlanzapine Versus An Active Comparator in the Treatment of SchizophreniaThe purpose of this study is to determine how Olanzapine compares to an active comparator in the treatment of schizophreniaNCT00036088·El Centro, California and 59 others

CompletedEffectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor)The aim is to evaluate the effectiveness of an intervention based on a program of physical activity and diet coordinated between primary care teams (PCT) and Mental Health Centres…NCT01729650·Barcelona, Barcelona

CompletedEye Blink Response in Healthy Volunteers and Adults With SchizophreniaThe purpose of this study is to explore how the brain works during particular memory tasks in people with schizophrenia and healthy volunteers.NCT00001920·Bethesda, Maryland

RecruitingA PET/MRI Study of Cobenfy on Dopamine Transmission in SchizophreniaThis is a single site clinical trial in which 12 participants with schizophrenia will be randomized to one of three doses of treatment with Cobenfy for 5 weeks.NCT07423546·New York, New York

PreviousPage 74 of 214Next